Literature DB >> 29790869

The effect of caffeine on the ventilatory response to hypercarbia in preterm infants.

Thomas Rossor1, Ravindra Bhat2, Kamal Ali2, Janet Peacock3, Gerrard F Rafferty1, Anne Greenough1.   

Abstract

BackgroundWe tested the hypotheses that caffeine therapy would increase the ventilatory response to hypercarbia in infants above the effect of maturation and those with a weaker ventilatory response to hypercarbia would be more likely to subsequently develop apnea that required treatment.MethodsInfants born at less than 34 weeks of gestation underwent a steady-state hypercarbic challenge using 0, 2, and 4% carbon dioxide soon after birth that was repeated at weekly intervals. The results of the initial study were compared between infants who did or did not subsequently develop apnea requiring treatment with caffeine.ResultsTwenty-six infants born at a median gestation of 32 (range 31-33) weeks were assessed. Caffeine administration was associated with an increase in CO2 sensitivity, and the mean increase was 15.3 (95% CI: 1-30) ml/kg/min/% CO2. Fourteen infants subsequently developed apnea treated with caffeine. After controlling for gestational age and birth weight, they had significantly lower carbon dioxide sensitivity at their initial study compared with those who did not require treatment.ConclusionCaffeine administration was associated with an increase in the ventilatory response to hypercarbia. An initial weaker ventilatory response to hypercarbia was associated with the subsequent development of apnea requiring treatment with caffeine.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29790869     DOI: 10.1038/pr.2018.48

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  27 in total

Review 1.  Plasticity in respiratory motor control: intermittent hypoxia and hypercapnia activate opposing serotonergic and noradrenergic modulatory systems.

Authors:  R Kinkead; K B Bach; S M Johnson; B A Hodgeman; G S Mitchell
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2001-09       Impact factor: 2.320

Review 2.  The brainstem respiratory network: an overview of a half century of research.

Authors:  Armand L Bianchi; Christian Gestreau
Journal:  Respir Physiol Neurobiol       Date:  2009-05-04       Impact factor: 1.931

3.  Effect of prone and supine position on sleep, apneas, and arousal in preterm infants.

Authors:  Ravindra Y Bhat; Simon Hannam; Ronit Pressler; Gerrard F Rafferty; Janet L Peacock; Anne Greenough
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

4.  Dose effect of caffeine on control of breathing and respiratory response to CO2 in cats.

Authors:  M Mazzarelli; N Jaspar; W A Zin; J V Aranda; J Milic-Emili
Journal:  J Appl Physiol (1985)       Date:  1986-01

5.  The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies.

Authors:  D J Henderson-Smart
Journal:  Aust Paediatr J       Date:  1981-12

6.  Changes in respiratory pattern resulting from the use of a facemask to record respiration in newborn infants.

Authors:  P J Fleming; M R Levine; A Goncalves
Journal:  Pediatr Res       Date:  1982-12       Impact factor: 3.756

7.  Depression of ventilatory responses after daily, cyclic hypercapnic hypoxia in piglets.

Authors:  K A Waters; K D Tinworth
Journal:  J Appl Physiol (1985)       Date:  2001-03

8.  Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity.

Authors:  Ying-Jie Peng; Nanduri R Prabhakar
Journal:  J Appl Physiol (1985)       Date:  2003-12-05

Review 9.  Neonatal apnea: what's new?

Authors:  Jalal M Abu-Shaweesh; Richard J Martin
Journal:  Pediatr Pulmonol       Date:  2008-10

10.  Sleeping position and responses to a carbon dioxide challenge in convalescent prematurely born infants studied post-term.

Authors:  Tolulope Saiki; Anthony D Milner; Simon Hannam; Gerrard F Rafferty; Janet L Peacock; Anne Greenough
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-01-28       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.